Neurology
The Next Frontier in Neurological Diagnostics and Therapeutics
Dave Rosa
NeuroOne
PAO-05-24-CL-02May 30, 2024
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Andrea Small-Howard, Ph.D.
Gb Sciences, Inc.
PAO-08-022-CL-01Sep 06, 2022
Clinical Trials
Late-Stage Positive Results Reported for Nerve Growth Factor Inhibitor
Nice Insight
PAO-M02-19-NI-017Feb 21, 2019
Study Results
Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Teva Pharmaceutical Industries
PR-M09-18-NI-051Sep 18, 2018
FDA
DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII
DURECT Corporation
PR-M08-18-NI-059Aug 15, 2018